Publications

Scientific publications

Editorials and Commentaries

Scientific Presentations

The Lancet (June 2020): Kuderer et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Cancer Discovery (October 2020): Rivera et al. Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study
Annals of Oncology (March 2021) Grivas et al. Association of Clinical Factors and Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium
JAMA Oncology (June, 2021) Thompson et al. Convalescent Plasma and Improved Survival in Patients with Hematologic Malignancies and COVID-19.

Scientific Presentations

Editorials and Commentaries

Scientific Presentations

ASCO 2020 LBA110 (Warner; May 28, 2020): Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19)
ISTH 2020 Congress (Rosovsky; July 12-14, 2020) Venous Thrombotic Complications in Cancer Patients with SARS-CoV-2 Infection: Report from the COVID-19 and Cancer Consortium (CCC19) Registry Analysis
AACR COVID-19 and Cancer virtual meeting (Peters; July 21, 2020): Flexibility to sustain solidity: Addressing new vulnerabilities in cancer at the time of COVID-19
AACR COVID-19 and Cancer virtual meeting (Rini; July 22, 2020): Understanding the impact of COVID in cancer patients through the COVID-19 and Cancer (CCC-19) and other COVID consortiums
ESMO 2020 LBA71 (Wise-Draper; Sep 19, 2020): Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis
ESMO 2020 LBA72 (Grivas; Sep 20, 2020): Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19)
Blood (2020) 136 (Supplement 1): 28–30: Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis
ASH 2020 #204 (Li; Dec 5, 2020) Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry
SABC 2021 # PS7-01 (Khaki; Dec, 2020) Characteristics and outcomes of SARS-CoV-2 infection in patients with invasive breast cancer (BC) from the COVID-19 and cancer consortium (CCC19) cohort study
ACC 2021 (Moey; May 16, 2021) Clinical characteristics and outcomes in cardio-oncology patients with covid-19: analysis from the covid-19 and cancer consortium (CCC19) database

Editorials and Commentaries

Editorials and Commentaries

Editorials and Commentaries

The Cancer Letter (Mar 20, 2020): COVID-19 and Cancer Consortium
AACR Blog (Mar 25, 2020): COVID-19 and Cancer Consortium Forms to Collect and Share Information
Nature Cancer (Apr 21, 2020): Crowdsourcing a crisis response for COVID19 in Oncology
Cancer Cell (Apr 27, 2020): The COVID-19 & Cancer Consortium (CCC19): a collaborative effort to understand the effects of COVID-19 on patients with cancer
The Cancer Letter (May 22, 2020): CCC19 bridging the knowledge gap for patients with COVID-19 and cancer
The Cancer Letter (May 29, 2020): CCC19 data point to extensive use of hydroxychloroquine, azithromycin, or both, by patients with cancer and COVID-19
The Lancet (May 29, 2020): Cancer and COVID-19: what do we really know?
JCO Clinical Cancer Informatics (June 17, 2020): Crowdsourcing in Crisis: Rising to the Occasion
Cancer Cell (Dec 14, 2020): The COVID-19 and Cancer Consortium - A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19:CCC19 Governance, Protocol, and Quality Assurance
Advances in Radiation Oncology (October 29, 2020): The COVID-19 and Cancer Consortium (CCC19) and Opportunities for Radiation Oncology
Cancer Cell (15 April 2021): Care without a compass: including patients with cancer in COVID-19 studies

Media

Podcasts/Interviews

Editorials and Commentaries

OncLive (Mar 18, 2020): Cancer Registry Launches to Inform COVID19+ Patient Demographics
Cancer Network (Mar 20, 2020): CCC19 Registry Launched to Understand COVID-19 in Patients with Cancer
ASCO Daily News (Mar 25, 2020): The Blind Leading the Blind: COVID19, Cancer, and the Need for more data
Urotoday (Mar 25, 2020): COVID19 and Cancer Consortium (CCC19)
ASCO Daily News (Mar 26, 2020): Cancer Consortium Launches COVID19 Registry in Urgent Appeal for Data to Save Lives at Risk from Infection
ASCO Post (Mar 27, 2020): The Blind Leading the Blind: COVID19, Cancer, and the Need for more data
Medicine Matters Oncology (Mar 27, 2020): COVID-19 cancer registry launched in the USA
Onconews, Brazil (Mar 28, 2020): Intitative gathers data on COVID-19 and cancer
Practice Update (Apr 1, 2020): Immediate Impact of COVID-19 on Cancer Care at Major Institutions.
SWOG: The Front Line (Apr 3, 2020): COVID Registry gets its start on Twitter
ASH Clinical News (Apr 9, 2020): COVID19, Cancer and Need for Clarity
British Medical Journal News (Apr 17,2020): COVID19 is shattering US cancer care
OncLive (Apr 18,2020): COVID19 and Cancer Consortium Gains International Ground
Frontline (May 4,2020): As Pandemic claims non-COVID patients, some face difficult decisions
Cancer Therapy Advisor (May 7, 2020) : Researchers Turn to Crowdsourcing To Learn More About COVID19 and Cancer
Associated Press (May 28, 2020): Cancer, coronavirus are a dangerous mix, new studies find
Cancer Network (May 28,2020): Cancer Progression Linked to Increased Risk of Death within 30 days of COVID19 diagnosis
CNN (May 28, 2020): How having cancer can put Covid-19 patients at higher risk of dying
MedPageToday (May 28, 2020): HCQ Linked to Harm in Cancer Patients
Reuters Health News (May 28, 2020): Hydroxychloroquine combination risky for cancer patients with COVID19
USA Today (May 28,2020): New study shows more cancer patients die from COVID19, but not necessarily for the reasons you'd expect
Wall Street Journal (May 28, 2020): Higher Death Rates Found Among Cancer Patients with COVID19
Medscape (May 29, 2020): Active Cancer Increases Death Risk in Patients With COVID-19
The Financial Express (May 30, 2020): Death Risk higher in cancer patients
healthline (June 9, 2020): People with Cancer Have to Choose Between Treatment and COVID-19 Risks
ASCO Post (June 12, 2020): Factors Associated With All-Cause 30-Day Mortality in Patients With Cancer Infected With COVID-19: CCC19 Database Analysis
Medscape (June 17, 2020): From a Tweet to the Lancet in 10 Weeks: COVID-Cancer Consortium
ASCO Post (June 24, 2020): Results of a COVID19 and Cancer Consortium (CCC19) Cohort Study
ASCO Post (June 25, 2020): COVID19 and Patients with Cancer: A Call to Action for Trainees
Medscape (July 27, 2020): CCC19, Other Registries Help Define COVID-19/Cancer Landscape
Elemental by Medium (August 5, 2020): The Unique Devastation of Cancer in a Pandemic
Healio (August 5, 2020): Hydroxychloroquine regimens for COVID-19 linked to mortality risk for patients with cancer
Cancer Therapy Advisor (August 12, 2020): The Twitter Effect on How Oncologists Conduct and Share Research
VUMC Reporter (Feb. 5, 2021): Convalescent plasma improved survival in COVID-19 patients with blood cancers
The Cancer Letter (March 19, 2021) The COVID-19 and Cancer Consortium - A year into building a United Front against the SARS-CoV-2 pandemic
UroToday (March 22, 2021): COVID-19 and Cancer Consortium Study Highlights Increased Mortality and Racial Disparities for Patients with Cancer Diagnosed with SARS-CoV-2 Infection
Onconews, Brazil (March 23, 2021): CCC19: Clinical factors, cancer treatment and severity of COVID-19 in cancer patients
Onconews, Brazil (March 23, 2021): CCC19: Clinical factors, cancer treatment and severity of COVID-19 in cancer patients
UT Health News (June 17, 2021) Blood cancer patients with COVID-19 fare better with convalescent plasma
Washington University School of Medicine News (June 17, 2021) Blood cancer patients with COVID-19 fare better with convalescent plasma

Podcasts/Interviews

Podcasts/Interviews

Podcasts/Interviews

ASCO Daily News (Mar 27, 2020): COVID19: How to Care for Patients With Cancer In a Global Pandemic
OncLive (Mar 30, 2020): Collaborative efforts lead to launch of COVID19 and Cancer Consortium registry
The Video Journal of Oncology (May 30, 2020): CCC19: COVID-19 and cancer
Practice Update (Mar 30, 2020): COVID19 registry for cancer patients: Rationale
IDSA COVID 19 Podcast (Apr 1, 2020): COVID19: What's Happening Now?
VuMedi (Apr 1, 2020): COVID-19 Pandemic: Preparation Protocols, Telemedicine and Modifying Treatment for Cancer Patients
eCancer (Apr 9, 2020): How COVID19 is impacting cancer patient care and clinical research
VuMedi (Apr 17, 2020): What is the COVID19 Cancer Consortium? Urgent need to generate knowledge on COVID19
OncLive (Apr 20, 2020): Dr. Choueiri on COVID19 and Cancer Consortium
Onconews (Apr 26, 2020): Crowdsourcing, COVID-19 and oncology
eCancer (May 13, 2020): The COVID19 and Cancer Consortium
Onconews (May 29, 2020): Global consortium shows results on cancer and COVID-19
Uromigos (May 29, 2020): Episode 27: COVID-19 in > 1000 Cancer Patients with Jeremy Warner (CCC-19)
CancerNetwork (May 29, 2020): Petros Grivas, MD, PhD, on the Future of the CCC19 Registry
VJOncology (May 30, 2020): CCC19: COVID-19 and cancer
ecancer (31 May, 2020): Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19)
Medicine Matters oncology (1 June, 2020): Initial data from CCC19
CancerNetwork (July 28, 2020): Jeremy L. Warner, MD, MS, on Updated Findings from the COVID-19 and Cancer Consortium
OnLive (August 14, 2020): Dr. Choueiri on the Significance of the CCC19 During the COVID-19 Crisis
Oncology Learning Network (Aug 18, 2020): Dr Lyman and Dr Desai Talk COVID-19, Cancer Care, and the CCC19 Initiative
OBRoncology (Sep 24, 2020): Petros Grivas, MD, PhD, discusses the COVID-19 and Cancer Consortium (CCC19) from ESMO 2020
VJOncology (Oct 2, 2020): CCC19: assessment of clinical and laboratory prognostic factors
VJOncology (Oct 5, 2020): CCC19: systemic cancer treatment-related outcomes
VuMedi (May 20, 2021): COVID-19 Severity Among Patients with Cancer (2021 Analysis): Which Anti-Cancer Drugs and Regimens Have High Associated Mortality?